Role of T cells during stem cell-driven regeneration: towards design of efficient stem cell-based therapies
T 细胞在干细胞驱动的再生过程中的作用:设计有效的基于干细胞的疗法
基本信息
- 批准号:15H06348
- 负责人:
- 金额:$ 1.91万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Research Activity Start-up
- 财政年份:2015
- 资助国家:日本
- 起止时间:2015-08-28 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
As we are facing an aging population, regenerative medicine will play a key role in patient care. While the field is becoming one of the next major innovations in healthcare, clinical translations of therapies are often very modest. For this research project, I hypothesized that tissue regeneration is strongly regulated by a crosstalk between the adaptive immune system and tissue-resident stem cells. Specifically, subsets of T cells could act as either “antiregenerative” or as “proregenerative”, by regulating stem cell functions.One the main goal for FY2015 was to determine which types of T cells and when are they recruited during stem cell-driven tissue healing. Using a bone regeneration model in the mouse, I found that T cells are recruited about 10 days following bone injury. The number of T cell is higher when the defects are treated with mesenchymal stem cells, especially the number of regulatory T cells.The second goal was to determine whether T cells modulate stem cell-driven tissue healing. I found that mice with more regulatory T cells (regulatory T cells injected i.v.) significantly regenerate bone faster. In addition, when defect are treated with mesenchymal stem cells, mice with more regulatory T cells significantly regenerate bone faster.The results of this research will serve as a base to design novel stem cell-based therapies.
当我们面临老龄化的人口时,再生医学将在患者护理中起关键作用。尽管该领域正在成为医疗保健领域的下一个主要创新之一,但疗法的临床翻译通常非常适中。对于该研究项目,我假设组织再生受到自适应免疫系统和组织居住的干细胞之间的串扰。具体而言,通过控制干细胞功能,T细胞的亚群可以用作“抗晶剂”或“促生生物”。2015财年的主要目标是确定哪种类型的T细胞,何时在干细胞驱动的组织组织愈合过程中募集。使用小鼠中的骨再生模型,我发现在骨损伤后约10天募集了T细胞。当缺陷用间充质干细胞(尤其是调节T细胞的数量)处理时,T细胞的数量较高。第二个目标是确定T细胞是否调节干细胞驱动的组织愈合。我发现具有更多调节性T细胞(调节性T细胞注入静脉注射的小鼠)的小鼠会更快地再生骨。此外,当用间充质干细胞处理缺陷时,具有更具调节性T细胞的小鼠会更快地再生骨。这项研究的结果将成为设计新型干细胞疗法的基础。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration.
- DOI:10.1038/ncomms11051
- 发表时间:2016-03-22
- 期刊:
- 影响因子:16.6
- 作者:Martino MM;Maruyama K;Kuhn GA;Satoh T;Takeuchi O;Müller R;Akira S
- 通讯作者:Akira S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTINO Mikael其他文献
MARTINO Mikael的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
抗MDA5自身抗体促进皮肌炎快速进展间质性肺炎的免疫学机制研究
- 批准号:82371804
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
异常激活的小胶质细胞通过上调CTSS抑制微血管特异性因子MFSD2A表达促进1型糖尿病视网膜病变的免疫学机制研究
- 批准号:82370827
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
病原体感染触发视神经脊髓炎谱系疾病(NMOSD)的免疫学机制研究
- 批准号:32300747
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从METRNL-KIT信号轴调控巨噬细胞探讨细菌性脓毒症与真菌性脓毒症的免疫学异质性,辅助诊断和治疗
- 批准号:82370009
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
组织蛋白酶E增强MIBC新辅助免疫化疗应答的免疫学机制研究
- 批准号:82373236
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
静脉脂肪干细胞移植对博来霉素诱导的硬皮病小鼠模型的抗炎和抗纤维化作用
- 批准号:
17K16216 - 财政年份:2017
- 资助金额:
$ 1.91万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Local transplantation of adipose- derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis
脂肪干细胞的局部移植对类风湿性关节炎小鼠模型具有显着的治疗效果
- 批准号:
17K11022 - 财政年份:2017
- 资助金额:
$ 1.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of hematopoietic stem cell products by using multiple cord blood units
利用多个脐带血单位开发造血干细胞产品
- 批准号:
17K16194 - 财政年份:2017
- 资助金额:
$ 1.91万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Therapeutic effect of mesenchymal stem cells by anti-inflammatory cytokinesIL-27 and IL-35
抗炎细胞因子IL-27和IL-35对间充质干细胞的治疗作用
- 批准号:
17K11030 - 财政年份:2017
- 资助金额:
$ 1.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel development of regenerative therapy following acute systemic inflammatory response syndrome: the effects of transplantation of bone marrow-derived mononuclear cells and new rejuvenation factor
急性全身炎症反应综合征再生治疗的新进展:骨髓源性单核细胞移植和新型回春因子的作用
- 批准号:
16H05498 - 财政年份:2016
- 资助金额:
$ 1.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)